Cardiac Surgery
Conditions
Keywords
Coronary artery bypass graft, Biomarker, Prognosis
Brief summary
This is a national registry study to determine the serumal biomarkers for prognosis of adverse events in patients undergoing coronary artery bypass grafting.
Interventions
A type of operation for coranary heart disease patients.
Sponsors
Study design
Eligibility
Inclusion criteria
1. Subject undergoing coronary artery bypass grafting; 2. Age is more than 18 and less than 80 years old; 3. Male and non pregnancy female; 4. Subject who understands study requirements and agrees to sign an informed consent from prior to study procedures.
Exclusion criteria
1. Pregnancy female; 2. Participate in other clinical trial in the last 1 month. 3. Subject who doesn't agree to sign an informed consent from prior to study procedures. 4. Subject undergoing repeat CABG, concomitant valve or other cardiac surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause death and cardiac death | These data is collected during follow-up visit at in-hospital/1 year after discharge |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Major adverse cardiac events (MACE) | These data is collected during follow-up visit at in-hospital/1 year after discharge | A composite of death, myocardial infarction, stroke, heart failure, ventricular arrhythmia |
Countries
China